Distinct expression patterns of the transcription factor E2F-I in relation to tumour growth parameters in common human carcinomas

Journal of Pathology

Volumn 203, Issue 3, 2004, Pages 744-753

  Zacharatos, Panayotis ^a   Kotsinas, Athanassios ^a   Evangelou, Konstantinos ^a   Karakaidos, Panagiotis ^a   Vassiliou, Leandros V ^a   Rezaei, Nousin ^a   Kyroudi, Aspasia ^a   Kittas, Christos ^a   Patsouris, Eystratios ^a   Papavassiliou, Athanasios G ^b   Gorgoulis, Vassilis G ^a,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c NONE   (Greece)

Author keywords

Apoptosis; Breast carcinomas; Colon carcinomas; E2F 1; Proliferation; Prostate carcinomas; Superficial bladder transitional cell carcinomas; Tumour growth

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

APOPTOSIS; ARTICLE; BLADDER CARCINOMA; BREAST CARCINOMA; CANCER GROWTH; CARCINOGENICITY; CARCINOMA; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; COLON ADENOCARCINOMA; COLON CANCER; DNA REPAIR; DNA SYNTHESIS; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MITOSIS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; CELL CYCLE PROTEINS; CELL DIVISION; COLONIC NEOPLASMS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; URINARY BLADDER NEOPLASMS;

EID: 3242682558     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1582     Document Type: Article

References (41)

1. Wyllie AH. E2F1 selects tumour cells for both life and death. J Pathol 2002; 198: 139 141.
2. Bell LA, Ryan KM. Life and death decisions by E2F-1. Cell Death Differ 2004; 11: 137 142.
3. Black RA, Azizkhan-Clifford J. Regulation of E2F: a family of transcription factors involved in proliferation control. Gene 1999; 237: 281 302.
4. Stevaux O, Dyson NJ. A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol 2002; 14: 684 691.
5. Phillips AC, Vousden KH. E2F-1 induced apoptosis. Apoptosis 2001; 6: 173 182.
6. Dyson N. The regulation of E2F by pRb-family proteins. Genes Dev 1998; 12: 2245 2262.
7. Harbour JW, Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 2000; 14: 2393 2409.
8. Field SJ, Tsai FY, Kuo F, et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996; 85: 549 561.
9. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 1996; 85: 537 548.
10. La Thangue NB. The yin and yang of E2F-1: balancing life and death. Nature Cell Biol 2003; 5: 587 589.
11. Gorgoulis VG, Zacharatos P, Mariatos G, et al. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. J Pathol 2002; 198: 142 156.
12. Eymin B, Gazzeri S, Brambilla C, Brambilla E. Distinct pattern of E2F1 expression in human lung tumors: E2F1 is upregulated in small cell lung carcinoma. Oncogene 2001; 20: 1678 1687.
13. Zhang SY, Liu SC, Al-Saleem LF, et al. E2F-1: a proliferative marker of breast neoplasia. Cancer Epidemiol Biomarkers Prev 2000; 9: 395 401.
14. Moller MB, Kania PW, Ino Y, et al. Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A. Leukemia 2000; 14: 898 904.
15. Wilson CS, Butch AW, Lai R, et al. Cyclin D1 and E2F-1 immunoreactivity in bone marrow biopsy specimens of multiple myeloma: relationship to proliferative activity, cytogenetic abnormalities and DNA ploidy. Br J Haematol 2001; 112: 776 782.
16. Saiz AD, Olvera M, Rezk S, Florentine BA, McCourty A, Brynes RK. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions. J Pathol 2002; 198: 157 162.
17. Yamazaki K, Yajima T, Nagao T, et al. Expression of transcription factor E2F-1 in pancreatic ductal carcinoma: an immunohistochemical study. Pathol Res Pract 2003; 199: 23 28.
18. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998; 48: 6 29.
19. American Joint Committee on Cancer. Breast. In AJCC Cancer Staging Manual (5th edn), Ed by Frederick LG. Lippincott-Raven: Philadelphia, 1997; 171 178.
20. Gittes RF. Carcinoma of the prostate. N Engl J Med 1991; 324: 236 245.
21. Kyriakos M. The President's cancer, the Dukes classification, and confusion. Arch Pathol Lab Med 1985; 109: 1063 1066.
22. Beahrs JR, Fleming TR, Zincke H. Risk of local urethral recurrence after radical cystectomy for bladder cancer. J Urol 1984; 131: 264 266.
23. Gorgoulis VG, Zacharatos P, Kotsinas A, et al. Alterations of the p16 pRb pathway and the chromosome locus 9p21 22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression. Am J Pathol 1998; 153: 1749 1765.
24. Kouvaraki M, Gorgoulis VG, Rassidakis GZ, et al. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors. Cancer 2002; 94: 2454 2465.
25. Gorgoulis VG, Zacharatos P, Kotsinas A, et al. Altered expression of the cell cycle regulatory molecules pRb, p53 and MDM2 exerts a synergetic effect on tumor growth and chromosomal instability in non-small cell lung carcinomas (NSCLCs). Mol Med 2000; 6: 208 237.
26. Gorgoulis VG, Koutroumbi EN, Kotsinas A, et al. Alterations of p16 pRb pathway and chromosome locus 9p21 22 in sporadic invasive breast carcinomas. Mol Med 1999; 4: 807 822.
27. Baithun SI, Naase M, Blanes A, Diaz-Cano SJ. Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications. Virchows Arch 2001; 438: 289 297.
28. Yasui W, Fujimoto J, Suzuki T, et al. Expression of cell-cycle-regulating transcription factor E2F-1 in colorectal carcinomas. Pathobiology 1999; 67: 174 179.
29. Rabbani F, Richon VM, Orlow I, et al. Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. J Natl Cancer Inst 1999; 91: 874 881.
30. Pich A, Chiusa L, Formiconi A, et al. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder. Cancer 2002; 95: 784 790.
31. Strom DK, Cleveland JL, Chellappan S, Nip J, Hiebert SW. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation. Cell Growth Differ 1998; 9: 59 69.
32. Sionov RV, Haupt Y. The cellular response to p53: the decision between life and death. Oncogene 1999; 18: 6145 6157.
33. Yamasaki L. Balancing proliferation and apoptosis in vivo: the Goldilocks theory of E2F/DP action. Biochim Biophys Acta 1999; 1423: M9 M15.
34. Muller H, Helin K. The E2F transcription factors: key regulators of cell proliferation. Biochim Biophys Acta 2000; 470: M1 M12.
35. Loden M, Stighall M, Nielsen NH, et al. The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorigenesis based on pattern of genetic aberrations and inactivation of the pRb node. Oncogene 2002; 21: 4680 4690.
36. Irwin M, Marin MC, Phillips AC, et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 2000; 407: 645 648.
37. Han S, Semba S, Abe T, et al. Infrequent somatic mutations of the p73 gene in various human cancers. Eur J Surg Oncol 1999; 25: 194 198.
38. Vorburger SA, Pataer A, Yoshida K, et al. The mitochondrial apoptosis-inducing factor plays a role in E2F-1-induced apoptosis in human colon cancer cells. Ann Surg Oncol 2003; 10: 314 322.
39. Elliott MJ, Dong YB, Yang H, McMasters KM. E2F-1 up-regulates c-Myc and p14 (ARF) and induces apoptosis in colon cancer cells. Clin Cancer Res 2001; 7: 3590 3597.
40. Yamamoto H, Sob JW, Monden T, et al. Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis. Clin Cancer Res 1999; 5: 1805 1815.
41. Kaelin WG. E2F1 as a target: promoter-driven suicide and small molecule modulators. Cancer Biol Ther 2003; 2: (4 Suppl 1): S48 S54.